JP2014522868A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014522868A5 JP2014522868A5 JP2014523080A JP2014523080A JP2014522868A5 JP 2014522868 A5 JP2014522868 A5 JP 2014522868A5 JP 2014523080 A JP2014523080 A JP 2014523080A JP 2014523080 A JP2014523080 A JP 2014523080A JP 2014522868 A5 JP2014522868 A5 JP 2014522868A5
- Authority
- JP
- Japan
- Prior art keywords
- preparation
- protein
- acid sequence
- amino acid
- chimeric cytokine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161513453P | 2011-07-29 | 2011-07-29 | |
| US61/513,453 | 2011-07-29 | ||
| US201261591727P | 2012-01-27 | 2012-01-27 | |
| US61/591,727 | 2012-01-27 | ||
| PCT/US2012/048631 WO2013019652A1 (en) | 2011-07-29 | 2012-07-27 | Purified proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014522868A JP2014522868A (ja) | 2014-09-08 |
| JP2014522868A5 true JP2014522868A5 (cg-RX-API-DMAC7.html) | 2015-09-17 |
Family
ID=46682907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014523080A Pending JP2014522868A (ja) | 2011-07-29 | 2012-07-27 | 精製タンパク質 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20140341843A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2736524A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2014522868A (cg-RX-API-DMAC7.html) |
| CN (1) | CN104066439A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2012290379A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112014002173A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2843197A1 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2014107743A (cg-RX-API-DMAC7.html) |
| SG (1) | SG10201606218WA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013019652A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20230776T1 (hr) | 2010-07-29 | 2023-10-27 | Buzzard Pharmaceuticals AB | Himerni antagonisti receptora il-1 tipa i |
| JP6450364B2 (ja) * | 2013-03-13 | 2019-01-09 | セセン バイオ, インコーポレイテッド | 眼送達のためのキメラサイトカイン製剤 |
| AU2013203043B2 (en) | 2013-03-15 | 2016-10-06 | Takeda Pharmaceutical Company Limited | Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs |
| DK3461891T3 (da) * | 2014-01-24 | 2020-08-10 | Am-Pharma Bv | Nedstrømsbehandling af en alkalisk phosphatase |
| WO2015138844A1 (en) * | 2014-03-13 | 2015-09-17 | Eleven Biotherapeutics, Inc. | Methods for production of stable chimeric cytokine protein formulations in blow fill seal containers |
| SG11201702757YA (en) * | 2014-10-23 | 2017-05-30 | Ngm Biopharmaceuticals Inc | Pharmaceutical compositions comprising peptide variants and methods of use thereof |
| TW201702380A (zh) * | 2015-02-27 | 2017-01-16 | 再生元醫藥公司 | 宿主細胞蛋白質修飾 |
| CN104710527B (zh) * | 2015-02-28 | 2018-08-24 | 苏州金盟生物技术有限公司 | 一种生物制品的内毒素去除方法 |
| CN115598231B (zh) * | 2016-08-15 | 2025-11-18 | 豪夫迈·罗氏有限公司 | 定量包含非离子表面活性剂和多肽的组合物中非离子表面活性剂的层析方法 |
| AU2021262609A1 (en) | 2020-05-01 | 2022-12-22 | Kashiv Biosciences, Llc | An improved process of purification of protein |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA811368B (en) | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
| US5693489A (en) | 1984-03-30 | 1997-12-02 | Associated Universities, Inc. | Cloning and expression of the gene for bacteriophage T7 RNA polymerase |
| US4770781A (en) * | 1986-03-03 | 1988-09-13 | Merck & Co., Inc. | Purification of human interleukin-1 species |
| US4883658A (en) | 1986-04-28 | 1989-11-28 | Holly Frank J | Ophthalmic solution for treatment of dry-eye syndrome |
| US4804539A (en) | 1986-07-28 | 1989-02-14 | Liposome Technology, Inc. | Ophthalmic liposomes |
| US4801686A (en) * | 1986-09-04 | 1989-01-31 | Immunex Corporation | Purification of recombinant interleukin-1 |
| US5278151A (en) | 1987-04-02 | 1994-01-11 | Ocular Research Of Boston, Inc. | Dry eye treatment solution |
| JP2799483B2 (ja) * | 1988-03-09 | 1998-09-17 | 大塚製薬株式会社 | インターロイキン−1β組成物の安定化方法 |
| AU4005289A (en) | 1988-08-25 | 1990-03-01 | Smithkline Beecham Corporation | Recombinant saccharomyces |
| US5075104A (en) | 1989-03-31 | 1991-12-24 | Alcon Laboratories, Inc. | Ophthalmic carboxy vinyl polymer gel for dry eye syndrome |
| HK1006856A1 (en) * | 1989-11-29 | 1999-03-19 | Amgen Inc. | Production of recombinant human interleukin-1 inhibitor |
| ZA912797B (en) | 1990-05-29 | 1992-12-30 | Boston Ocular Res | Dry eye treatment process and solution |
| ATE257389T1 (de) * | 1992-09-17 | 2004-01-15 | Amgen Inc | Pharmazeutische zusammensetzungen mit interleukin-1 inhibitoren |
| US5739277A (en) | 1995-04-14 | 1998-04-14 | Genentech Inc. | Altered polypeptides with increased half-life |
| EP0938501B1 (en) * | 1996-06-07 | 2004-07-28 | AVENTIS BULK S.p.A. | Process for the purification of human interleukin-1 receptor antagonist from recombinant e. coli |
| CA2273852C (en) * | 1996-12-06 | 2009-09-29 | Amgen Inc. | Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases |
| EP1355919B1 (en) | 2000-12-12 | 2010-11-24 | MedImmune, LLC | Molecules with extended half-lives, compositions and uses thereof |
| PL1729810T3 (pl) * | 2004-04-02 | 2019-02-28 | Swedish Orphan Biovitrum Ab (Publ) | Sposoby agregacji IL-1ra |
| US7700318B2 (en) * | 2004-08-25 | 2010-04-20 | Amprotein Corporation | Chimeric polypeptide and use thereof |
| CA2589802A1 (en) * | 2004-12-02 | 2006-06-08 | Domantis Limited | Plad domain peptides with increased serum half life due to conjugation to domain antibodies |
| US8563521B2 (en) | 2007-06-21 | 2013-10-22 | Technische Universitat Munchen | Biological active proteins having increased in vivo and/or in vitro stability |
| CA2695374A1 (en) | 2007-08-15 | 2009-02-19 | Amunix, Inc. | Compositions and methods for modifying properties of biologically active polypeptides |
| WO2011063195A2 (en) * | 2009-11-20 | 2011-05-26 | Dr. Reddy's Laboratories Ltd. | Purification of modified cytokines |
| HRP20230776T1 (hr) * | 2010-07-29 | 2023-10-27 | Buzzard Pharmaceuticals AB | Himerni antagonisti receptora il-1 tipa i |
| WO2012103240A2 (en) * | 2011-01-25 | 2012-08-02 | Eleven Biotherapeutics, Inc. | Receptor binding agents |
-
2012
- 2012-07-27 SG SG10201606218WA patent/SG10201606218WA/en unknown
- 2012-07-27 WO PCT/US2012/048631 patent/WO2013019652A1/en not_active Ceased
- 2012-07-27 EP EP12748087.9A patent/EP2736524A1/en not_active Withdrawn
- 2012-07-27 BR BR112014002173A patent/BR112014002173A2/pt not_active IP Right Cessation
- 2012-07-27 US US14/235,777 patent/US20140341843A1/en not_active Abandoned
- 2012-07-27 RU RU2014107743/10A patent/RU2014107743A/ru not_active Application Discontinuation
- 2012-07-27 CA CA2843197A patent/CA2843197A1/en not_active Abandoned
- 2012-07-27 AU AU2012290379A patent/AU2012290379A1/en not_active Abandoned
- 2012-07-27 JP JP2014523080A patent/JP2014522868A/ja active Pending
- 2012-07-27 CN CN201280046036.2A patent/CN104066439A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8329871B2 (en) | Process of purifying coagulation factor VIII | |
| Lampi et al. | Lens proteomics: analysis of rat crystallin sequences and two-dimensional electrophoresis map | |
| US7999085B2 (en) | Enhanced capacity and purification of protein by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers | |
| JP7270085B2 (ja) | ナノ粒子製剤 | |
| EP3325614B1 (en) | Methods for purifying adenovirus vectors | |
| JP2010529958A5 (cg-RX-API-DMAC7.html) | ||
| WO2015067781A1 (en) | New methods to produce active tert | |
| RU2014107743A (ru) | Очищенные белки | |
| RU2019109975A (ru) | Способы очистки антител | |
| JP2008054693A (ja) | 酵母宿主から真性のigfを精製するための方法 | |
| JP6232130B2 (ja) | ダルベポエチンアルファの精製方法 | |
| CA2956316C (en) | Method for purifying antibodies | |
| CA3014567C (en) | Method for producing activated hepatocyte growth factor (hgf) | |
| Liu et al. | TbPIF1, a Trypanosoma brucei mitochondrial DNA helicase, is essential for kinetoplast minicircle replication | |
| US20250215050A1 (en) | Compositions and methods for purifying biological fluids | |
| US11584777B2 (en) | Method for purifying a sulfatase protein | |
| Balagurunathan et al. | Enhancement of stability of recombinant streptokinase by intracellular expression and single step purification by hydrophobic interaction chromatography | |
| US20200131225A1 (en) | Methods of purification of albumin fusion proteins | |
| CA2847818A1 (en) | Methods for processing coagulation factors | |
| US11919924B1 (en) | Methods of purifying and producing an adalimumab antibody | |
| Rajamanickam et al. | Comparison of Purification Strategies of Three Horseradish PeroxidaseIsoenzymes Recombinantly Produced in Pichia pastoris | |
| JP5750471B2 (ja) | 組換え体ヒトfshの製造方法 | |
| RU2683950C1 (ru) | Способ очистки рекомбинантного тканевого активатора плазминогена для медицинского применения | |
| JP2017186278A (ja) | 標的タンパク質の精製方法 | |
| JP2001139600A (ja) | Il−6r・il−6融合蛋白質の精製方法 |